Continuous Renal Replacement Therapy Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) – Forecast to 2022
The global Continuous Renal Replacement Therapy market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Growing number of ICU patients, increasing incidence of sepsis, rising incidence of acute kidney injuries, technological advancements, and clinical advantages of CRRT over intermittent blood purification techniques are some of the key factors driving the growth of the market.
Drivers
1 Increasing Global Incidence of AKI
2 Growing Number of Icu Patients
3 Clinical Advantages of CRRT Over Intermittent Blood Purification Techniques
4 Technological Advancements and New Product Launches
5 Increasing Incidence of Sepsis
6 Growing Prevalence of Diabetes and Hypertension
PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=246917088
Restraints
1 High Procedural Cost of CRRT
2 Stringent Regulatory Guidelines for CRRT in North America
Opportunities
1 Emerging Markets
2 Increasing Applications of CRRT
3 Ongoing Research to Establish Safety and Efficacy Profile of CRRT
4 Development of CRRT System for Pediatric Patients
5 Untapped Growth Opportunities in North American Market
Challenges
1 High Complexity of CRRT Therapy
2 Shortage of Trained Icu Nurses in Developed Countries
3 Poor Reimbursement Scenario in Developing Countries
4 Lack of Awareness About Benefits of CRRT
